Contract 75D30126D20713
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · December 29, 2025
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on December 29, 2025 for $123,000 of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2026. If all options are exercised, the contract could reach $9.30 million.
Contract details
- PIID
- 75D30126D20713
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- December 29, 2025
- Latest action
- March 31, 2026
Description
ADULT FLU VACCINES
Modification timeline
-
March 31, 2026Mod P00002 · Other Administrative Action$122.8K
-
March 9, 2026Mod P00001 · Funding Only Action$122.8K
-
December 29, 2025Base award$1.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Biocryst Pharmaceuticals Inc | Department Of Health And Human Services | March 27, 2026 | $13.88M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 27, 2026 | $176.14M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30126D20713?
Contract 75D30126D20713 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on December 29, 2025 for $123,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75D30126D20713?
Astrazeneca Pharmaceuticals Lp won contract 75D30126D20713 from Department Of Health And Human Services.
How much is contract 75D30126D20713 worth?
Contract 75D30126D20713 has obligated $123,000 to date, with a total potential value of $9.30 million if all options are exercised.